Study on the Adjustment Path of Chinese Pharmaceutical Industry's Organizational Structure under the Background of Evaluation and Approval System Reform

Wang Guangping, Shi Shengyi, Wang Ying, Hu Jun

Chinese Pharmaceutical Affairs ›› 2019, Vol. 33 ›› Issue (1) : 1-11.

PDF(3046 KB)
PDF(3046 KB)
Chinese Pharmaceutical Affairs ›› 2019, Vol. 33 ›› Issue (1) : 1-11. DOI: 10.16153/j.1002-7777.2019.01.001
Supervision Administration

Study on the Adjustment Path of Chinese Pharmaceutical Industry's Organizational Structure under the Background of Evaluation and Approval System Reform

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2019, 33(1): 1-11 https://doi.org/10.16153/j.1002-7777.2019.01.001

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(3046 KB)

Accesses

Citation

Detail

Sections
Recommended

/

〈 〉